跳到主要內容區塊
:::

醫師介紹

Print
    陳金順 CHEN Jin-Shuen
    陳金順 CHEN Jin-Shuen
    看診科別
    主治項目
    • 糖尿病腎病變 蛋白尿 血尿 電解質及酸鹼異常 各種腎功能異常 血液透析 腹膜透析 腎臟移植照護
    專長
    • 內科學 腎臟學
    • 膜性腎病變、糖尿病腎病變小鼠動物模式之建立及分析
    • 膜性腎病變、糖尿病腎病變與血纖維溶解脢原間之關係
    • 糖尿病腎病變之疾病生物標記
    • 末期腎病變生物資料庫之建立及分析
    現職
    • 教學研究部主任
    • 腎臟內科主治醫師
    • 國防醫學院醫學系教授
    • 中山大學合聘教授
    • 台灣腎臟醫學會秘書長
    • 藥害救濟審議事物臨床專家
    • 一般醫學訓練示範中心專家輔導團委員
    • 衛生福利部爭審委員會 委員
    學歷
    • 國防醫學院醫學系學士
    • 國防醫學院醫學科學研究所博士
    • 台大管理學院會計管理組碩士
    經歷
    • 三軍總醫院腎臟內科主任
    • 三軍總醫院基隆分院院長
    • 三軍總醫院民診處主任
    • 三軍總醫院一般醫學部主任
    • 台灣腎臟醫學會理事
    證照
    • 內科專科證書
    • 腎臟內科專科證書
    專案計畫
    • 以體內及體外模式研究Irisin、SPAK、u-PA系統在高脂及高糖誘發代謝器官傷害之調控機制(科技部三年計畫107-110 )MOST 107-2314-B-016 -040 -MY3
    • 以蛋白尿腎病變動物模式探討Irisin與uPA/uPAR之關係TSGH-C108-134(107-108)
    • 以細胞模式探討熱傷害與血纖維蛋白溶解酶原/uPAR系統及SPAK基因之關係(107-108)
    論著
    • 2017-2018
    • 1.Chou CL, Hsieh TC, Chen JS, Fang TC. Sudden Sensorineural Hearing Loss in Hemodialysis Patients Could be a Marker of Pathogenic Progression in the Mortality and Atherosclerotic Events: A National Cohort Study. Otol Neurotol. 2018 Sep 12.
    • 2.Chou CL, Li CH, Lin H, Liao MH, Wu CC, Chen JS, Sue YM, Fang TC. Role of activating transcription factor 3 in fructose-induced metabolic syndrome in mice. Hypertens Res. 2018 Aug;41(8):589-597
    • 3.Chang TJ, Zheng CM, Wu MY, Chen TT, Wu YC, Wu YL, Lin HT, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Lin YF. Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population. Sci Rep. 2018 May 2;8(1):6908.
    • 4.Huang HH, Chen YL, Chen JS, Lin JD, Hsieh CH, Pei D, Wu CZ. Relationships Among C-Reactive Protein, Alanine Aminotransferase, and Metabolic Syndrome in Apparently Healthy Chinese Subjects. Metab Syndr Relat Disord. 2018 Jun;16(5):232-239.
    • 5.Cheng CW, Chang CC, Chen HW, Lin CY, Chen JS. Serum ApoA4 levels predicted the progression of renal impairment in T2DM. Eur J Clin Invest. 2018 Jun;48(6):e12937.
    • 6.Chou CL, Hsieh TC, Chen JS, Fang TC. Risks of all-cause mortality and major kidney events in patients with new-onset primary open-angle glaucoma: a nationwide long-term cohort study in Taiwan. BMJ Open. 2018 Mar 22;8(3):e021270.
    • 7.Huang YS, Lu KC, Chao TK, Chen JS, Chen A, Guo CY, Hsieh HY, Shih HM, Sytwu HK, Wu CC. Role of melatonin receptor 1A and pituitary homeobox-1 coexpression in protecting tubular epithelial cells in membranous nephropathy. J Pineal Res. 2018 Aug;65(1):e12482.
    • 8.Huang YS, Fu SH, Lu KC, Chen JS, Hsieh HY, Sytwu HK, Wu CC. Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy. Oncotarget. 2017 Dec 4;8(67):111631-111641.
    • 10.Po-Jen Hsiao. Szu-Han Chiu. Kun-Lin Wu. Che-Fu Chang. Jenq-Shyong Chan, Jin-Shuen Chen. Life-Threatening Complications Following Percutaneous Ultrasound-Guided Renal Biopsy: a Rare Case Report. International Archives of Medicine, v. 10, mar. 2017. (Case report)
    • 11.Hyponatremia: Practice Approach and Its Pitfalls(低血鈉的評估及常見陷阱). Chen-Yi Liao, Chai-Chao Wu, Ming-Kai Tsa, I-Hung Chen, Chih-Chiang Wang, Ho-Cheng Lin, Jin-Shuen Chen. 腎臟與透析 ; 29卷1期 (2017 / 03 / 01) , P6 - 11
    • 12.Chien LN, Chou CL, Chen HH, Kao CC, Lin YC, Wu YL, Chen JS, Chen LY, Fang TC. Association Between Stroke Risk and Metformin Use in Hemodialysis Patients With Diabetes Mellitus: A Nested Case-Control Study. J Am Heart Assoc. 2017 Nov 16;6(11).
    • 13.Chou CL, Lin H, Chen JS, Fang TC.Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats. PLoS One. 2017 Jul 10;12(7):e0180712.
    • 14.Huang RY, Lin YF, Kao SY, Shieh YS, Chen JS. Dental Restorative Treatment Expenditure and Resource Utilization in Patients with Chronic Kidney Disease: A Nationwide Population-Based Study. J Dent Sci. 2017
    • (二)專利
    • 1.URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY. Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish No.: CN102300877B. China. Jan. 27. 2010
    • 2.Urine and serum biomarkers associated with diabetic nephropathy. Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish No.:US2011/0086371 A1. Unite States. Apr. 14. 2011.
    • 3.評估罹患糖尿病腎病變風險評估個體中糖尿病腎病變階段監測個體中糖尿病腎病變發展及評估個體中糖尿病的治療有效性之方法Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish TW1449910B.中華民國103年8月21日
    • 4.URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY. Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish No.: US8465980B2. Canada. Jun. 18. 2013
    • 5.URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY. Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish No.: US8476077B2. Jul,2,2013
    • 6.Urine and serum biomarkers associated with diabetic nephropathy. Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish No.:5689426. 平成27年2月6日(2015.2.6)
    • 7.Urine and serum biomarkers associated with diabetic nephropathy. Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Lin, Jin-Shuen Chen, Yen-Peng Li. Patent Application Publish No.EP2623517A.Aug,7,2013c Bromvalerylurea Intoxication. Acta Nephrologica. 24:79-84. 2010.
    :::